You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 5,278,284


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,278,284
Title: Protein purification method
Abstract:A method of removing a valuable protein from a complex solution and recovering the valuable protein in purified form consists of adding a silica gel sorbant having a pore size approximately the molecular size of the protein to a solution containing the protein, allowing the protein to be sorbed onto the sorbant, separating the sorbant from the solution and then recovering the protein from the sorbant.
Inventor(s): Lusk; Lance T. (Milwaukee, WI), Goldstein; Henry (Brookfield, WI)
Assignee: Miller Brewing Company (Milwaukee, WI)
Application Number:07/882,793
Patent Claims:1. A method of removing a protein from a solution containing that protein, said method comprising adding to a solution containing the protein an effective amount of a sorbant consisting essentially of a member selected from the group consisting of a silica hydrogen, a silica cogel and a silica xerogel, to sorb at least some of the protein, intimately distributing the sorbant through the solution and permitting the sorbant to remain in the solution until the protein has been sorbed thereon, then removing from the solution the sorbant with protein sorbed thereon and treating said sorbant with an eluent which will disrupt bonds between the sorbant and the protein and permit the protein to be separated from the sorbant and recovered.

2. A method of claim 1 in which the protein is antifreeze protein.

3. A method of claim 1 in which the protein is chymosin.

4. A method of claim 1 in which the protein is insulin.

5. A method of claim 1 in which the sorbant is a silica hydrogel.

6. A method of claim 1 in which the sorbant is a silica xerogel.

7. A method of claim 1 in which the sorbant is a silica cogel.

8. A method of claim 1 in which the eluent is a hydrophobic solvent.

9. A method of claim 1 in which the eluent is a solvent that disrupts hydrogen bonds.

10. A method of claim 1 in which the eluent is a solvent that disrupts ion exchange bonds.

11. A method of identifying whether a specific protein can be effectively removed from a specific solution containing said protein by treatment with a sorbant consisting essentially of a member selected from the group consisting of a silica hydrogel, a silica cogel and a silica zerogel, said method comprising adding an effective amount of the sorbant to a sample of the solution containing the valuable protein to sorb the protein, intimately mixing the sorbant with the solution, allowing the sorbant to remain in the solution long enough for the protein to become sorbed thereon, then removing the sorbant from the solution and treating the sorbant with different eluents to see which of the eluents disrupt the bonds between the protein and the sorbant so that the protein can be separated and recovered.

12. A method of removing a protein having a molecular weight of about 1,000 to 250,000 from an aqueous preparation containing that protein, said method comprising adding to the preparation containing said protein an effective amount of a silica sorbant selected from the group consisting of a silica hydrogel, a silica cogel and a silica xerogel to sorb at least some of the valuable protein, intimately distributing the sorbant through the preparation and permitting the sorbant to remain in the preparation until said protein has been sorbed thereon, then removing from the preparation the sorbant with said protein sorbed thereon, and treating said sorbant with an eluent which will disrupt bonds between the sorbant and said protein and permit said protein to be separated and recovered.

13. A method of removing antifreeze protein from a solution containing antifreeze protein, said method comprising adding to an aqueous preparation containing antifreeze protein an effective amount of a silica sorbant selected from the group consisting of a silica cogel and a silica hydrogel to sorb at least some of the antifreeze protein, intimately distributing the sorbant through the solution and permitting the sorbant to remain in the preparation until the antifreeze protein has been sorbed thereon, then removing from the preparation the sorbant with antifreeze protein sorbed thereon, and treating said sorbant with an eluent which will disrupt bonds between the sorbant and the antifreeze protein and permit the antifreeze protein to be separated and recovered.

14. A method of claim 13 in which the silica sorbant is a silica cogel containing magnesium and the eluent is an aqueous ethanol solution.

15. A method of claim 13 in which the silica sorbant is a silica hydrogel and the eluent contains Tris-buffer, pH 8.

16. A method of removing a protein selected from the group consisting of antifreeze protein, insulin, chymosin, aldolase, ovalbumin, chymotrypsinogen A, ribonuclease A, human epidermal growth factor, methionyl human growth hormone, tissue plasminogen activating factor, human gamma interferon, human interleukin 2, tumor necrosis factor, streptokinase, invertase, bovine lysozyme, human serum albumin, human lysozyme, superoxide dismutase and alcohol oxidase from an aqueous preparation containing said protein, said method comprising adding to the preparation containing said protein an effective amount of a silica sorbant selected from the group consisting of silica hydrogels, silica cogels and silica xerogels to sorb at least some of said protein, intimately distributing the sorbant through the preparation and permitting the sorbant to remain in the preparation until said protein has been sorbed thereon, then removing from the preparation the sorbant with said protein sorbed thereon and treating said sorbant with an eluent which will disrupt bonds between the sorbant and said protein and permit said protein to be separated and recovered.

Details for Patent 5,278,284

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Grifols Therapeutics Llc ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5 albumin (human) For Injection 101138 10/21/1942 ⤷  Try a Trial 2040-01-28
Baxalta Us Inc. BUMINATE, FLEXBUMIN albumin (human) Injection 101452 03/03/1954 ⤷  Try a Trial 2040-01-28
Csl Behring Ag ALBURX albumin (human) Injection 102366 07/23/1976 ⤷  Try a Trial 2040-01-28
Grifols Biologicals Llc ALBUTEIN albumin (human) Injection 102478 08/15/1978 ⤷  Try a Trial 2040-01-28
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 02/17/1995 ⤷  Try a Trial 2040-01-28
Instituto Grifols, S.a. HUMAN ALBUMIN GRIFOLS albumin (human) Injection 103352 06/11/2003 ⤷  Try a Trial 2040-01-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.